BC Week In Review | Mar 9, 2015
Company News

Astion, Cipher deal

Astion granted Cipher exclusive, worldwide rights to develop and commercialize Dermadexin , Pruridexin and ASF-1096 . Dermadexin and Pruridexin are topical barrier-repair creams containing Astion’s pyridine-3-carboxamide glyceryl monocaprylate (P3CGM). Dermadexin is approved for seborrheic dermatitis in Europe,...
Items per page:
1 - 1 of 1